UK Markets closed

HLK Biotech Holding Group, Inc. (AMHD)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00010.0000 (0.00%)
At close: 12:08PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 24.91
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 30.1600
52-week low 30.0001
50-day moving average 30.0007
200-day moving average 30.0421

Share statistics

Avg vol (3-month) 31.35k
Avg vol (10-day) 3N/A
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 8N/A
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 322 Feb 2018
Ex-dividend date 4N/A
Last split factor 21:1000
Last split date 322 Feb 2018

Financial highlights

Fiscal year

Fiscal year ends 29 Jun 1999
Most-recent quarter (mrq)30 Mar 2000

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-96.82%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-180k
EBITDA -701.16k
Net income avi to common (ttm)-1.04M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)185.72k
Total cash per share (mrq)N/A
Total debt (mrq)600k
Total debt/equity (mrq)N/A
Current ratio (mrq)0.16
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-441.75k
Levered free cash flow (ttm)-224.06k